LakeShore Cost Of Revenue vs Other Operating Expenses Analysis
| LSB Stock | 2.75 0.23 7.72% |
LakeShore Biopharma financial indicator trend analysis is infinitely more than just investigating LakeShore Biopharma Co, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LakeShore Biopharma Co, is a good investment. Please check the relationship between LakeShore Biopharma Cost Of Revenue and its Other Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Cost Of Revenue vs Other Operating Expenses
Cost Of Revenue vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LakeShore Biopharma Co, Cost Of Revenue account and Other Operating Expenses. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between LakeShore Biopharma's Cost Of Revenue and Other Operating Expenses is 0.51. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of LakeShore Biopharma Co,, assuming nothing else is changed. The correlation between historical values of LakeShore Biopharma's Cost Of Revenue and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of LakeShore Biopharma Co, are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Cost Of Revenue i.e., LakeShore Biopharma's Cost Of Revenue and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.51 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Cost Of Revenue
Cost of Revenue is found on LakeShore Biopharma Co, income statement and represents the costs associated with goods and services LakeShore Biopharma provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of LakeShore Biopharma Co,. It is also known as LakeShore Biopharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most indicators from LakeShore Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LakeShore Biopharma Co, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At present, LakeShore Biopharma's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 7.9 B, whereas Tax Provision is projected to grow to (20.6 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.7M | 30.9M | 44.3M | 29.6M | Depreciation And Amortization | 31.2M | 36.7M | 42.2M | 37.9M |
LakeShore Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
LakeShore Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LakeShore Biopharma Co, is a strong investment it is important to analyze LakeShore Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LakeShore Biopharma's future performance. For an informed investment choice regarding LakeShore Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 5.363 | Quarterly Revenue Growth 0.277 | Return On Assets (0.14) | Return On Equity (0.66) |
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.